Clinical Ovarian And Other Gynecologic Cancer Impact Factor

Posted on June 12, 2017 by Judy Schwartz Haley. Working on the special issue, Guest Editors Dr Susan C. ovaries made up of with three kinds of cells. Krok-Schoen , Brittany M. 26 Annually, more than 22,000 women in the U. The most common cancer combina - tion in those patients, is synchronous primary en - Clinical characteristics and current therapeutic approach of patients with synchronous primary endometrial and ovarian cancers. 56]) and clear cell (10. Progesterone can cause the growth of gynecologic cancer cells. Mouse models of ovarian carcinoma have been developed that recapitulate many of the morphological features, biological behavior, and gene-expression patterns of selected subtypes of ovarian cancer. Ovarian Cancer Vaccine for Patients in Remission The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. The incidence rate has remained relatively stable over the past 30 years with a 5-year relative survival of about 35%. Because p53 dysfunction is common in ovarian cancer, we chose to investigate whether specific types of mutations predicted a predisposition to distant metastasis. According to this definition, ROC has been characterized into four different. The stages of ovarian cancer range from 1–4, depending on the size of the tumor and how far it has spread throughout the body. Other non-cancerous (benign) conditions can also cause a high level. A clinical observational study was performed to investigate whether indicators that assess the risk of metastasis can identify recurrence earlier in OC patients. In fact, we are one of the few cancer centers in the nation to house a prestigious federally funded ovarian SPORE (Specialized Program of Research Excellence) program. For over 35 years the Journal of Obstetric, Gynecologic, & Neonatal Nursing (JOGNN) has been a premier resource for health care professionals committed to clinical scholarship that advances the. Introduction. It is the leading cause of death amongst gynecologic cancers. This cancer is largely preventable through screening and treatment of premalignant lesions. These genes also increase the risk of breast cancer. The journal Gynecologic Oncology, the official journal of the Society of Gynecologic Oncology, is pleased to announce the launch of a special issue on gynecologic cancer prevention, treatment and survivorship in obese women. The stages of ovarian cancer range from 1–4, depending on the size of the tumor and how far it has spread throughout the body. Some of the Gynecologic cancers are ovarian cancer, cervical cancer, uterine cancer, vulvar cancer and vaginal cancer. Insulin, adrenaline, thyroxine and melatonin are just a few of your many hormones. One hundred sixty-seven patients with gynecologic cancers were recruited from a district hospital in Southern Taiwan. 929, ranking it in the top 10% of journals in the Obstetrics and Gynecologic category of the Journal Citation Reports and in the top 30% in the. Stage II: Cancer is found in one or both ovaries and has spread into other areas of the pelvis. There are no good clinical predictors of this phenomenon. Known risk factors that may increase a woman’s chance of developing ovarian cancer include: Family History and Genetics - Heredity is a strong risk factor for ovarian cancer even though it only accounts for a limited number of cases. Ovarian cancer is the fifth most common cause of cancer deaths in women, with more than 22,000 diagnoses and around 14,000 deaths each year. The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Although risk factors often influence the development of cancer, most do not directly cause cancer. Some things reduce a woman’s risk of developing ovarian cancer. Two Faces of Cancer: Internationally Renowned Oncologist & Ovarian Cancer Expert Dr. testing in ovarian cancer clinical practice. Clinical Ovarian and other Gynecologic Cancer. A comprehensive listing of over 250 oncology and related journals. DATA SOURCES: We searched MEDLINE, EMBASE, Cochrane Library, Web of Science Core Collection from inception to June 2018. The journal Gynecologic Oncology, the official journal of the Society of Gynecologic Oncology, is pleased to announce the launch of a special issue on gynecologic cancer prevention, treatment and survivorship in obese women. 817C > T in exon8. In December 2011, two positive phase III trials1, 2 that assessed bevacizumab in patients with ovarian cancer were reported in the New England Journal of Medicine; these results led to the EMA approval of the drug as first-line treatment in combination with carboplatin and paclitaxel for this disease. As consultants, they have all-encompassing preparation in the identification and treatment of these cancers. Since 1985, the International Gynecologic Cancer Society (IGCS) has been uniting the globe in the fight against gynecologic cancer by contributing to the prevention, treatment and study of gynecologic cancer, as well as improvement in the quality of life among women suffering from gynecologic cancer throughout the world. For ASCO information and resources, visit asco. Ovarian cancer is believed to occur due to changes in cell DNA. What every clinician should know Adjuvant chemotherapy after optimal primary cytoreductive surgery has been shown to improve progression-free and overall. An ethics review committee at the university approved the study and all participants provided informed consent. Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. 929, ranking it in the top 10% of journals in the Obstetrics and Gynecologic category of the Journal Citation Reports and in the top 30% in the. and 14,180 deaths would result. Early diagnosis carries a high survival rate of 93%. Introduction. This cancer is largely preventable through screening and treatment of premalignant lesions. The clinical trial enrolled 537 women with newly diagnosed ovarian cancer who had been treated with platinum-based chemotherapy plus Avastin. One of the most important factors influencing the outcome of treatment is the amount of tumor that remains after the initial surgery (ie, the success of the initial. The European Journal of Cancer (EJC) integrates preclinical, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. The Annals of Gynecologic cancer covers all latest research studies and developments in this field and reaches out to the right target audience. But other studies have reported that most epithelial ovarian cancer survivors were satisfied with their global quality of life, despite persistent psychological and physical symptoms. Cancer of the uterine cervix is the third most common gynecologic cancer diagnosis and cause of death among gynecologic cancers in the United States [1]. Gynecologic Cancer Comprehensive Brochure : Detailed information about each type of gynecologic cancer, including signs, symptoms, risk factors, and prevention. A family history of ovarian cancer, breast cancer, or certain other cancers also increases risk. A comprehensive listing of over 250 oncology and related journals. At NYU Langone, our gynecologic oncologists—doctors who specialize in diagnosing and treating cancers that develop in a woman's reproductive organs—work closely with our genetic counselors and breast cancer doctors. Markman M, Liu PY, Moon J, Monk BJ, Copeland L, Wilczynski S, et al. The authors present a well written review on the current status of p53 mutation/dysfunction in various gynecologic cancers such as endometrial, cervical, and ovarian cancer. Pages in category "Oncology journals" The following 117 pages are in this category, out of 117 total. At the time of diagnosis and first treatment, ovarian cancers are assigned to a stage based upon tumor size, the involvement of lymph nodes and the spread to body parts beyond the lymph nodes. This includes: clinical radiotherapy, combined modality treatment, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects relevant to oncology, particularly in the field of imaging, dosimetry and radiation therapy planning. Besides ultrasound, anatomic imaging with computed tomography (CT) and magnetic resonance (MR) imaging has long been used in clinical practice to ascertain disease extent and to detect peritoneal disease spread in patients with OC. Journal of the American College of Surgeons the official scientific journal of the American College of Surgeons, is a monthly peer-reviewed journal publishing original contributions on all aspects of surgery. Infórmese sobre el cáncer ginecológico (español / Spanish) “Striving for a Healthier Tomorrow, Today” NJ statewide symposium on gynecologic cancer held on November 19, 2015. This means that this test does not conclusively diagnose or rule out ovarian cancer but it can be a helpful test. Results The strong evidence for a positive association between diabetes mellitus and the risk for cancer indicates that energy intake in excess to energy expenditure, or the sequelae thereof, is involved in gynecological. testing in ovarian cancer clinical practice. The law of unintended consequences is that the actions of people, and especially of governments, will have effects that are unanticipated or unintended. a cancer diagnosis other than breast or ovarian cancer, clinical indications for germline (inherited) testing, risk factors for germline (inherited) cancer other than inherited breast or ovarian cancer, and; not been previously tested using NGS. Ovarian cancer is among the most dreaded cancers since it is often found at a late stage where the opportunity for extended survival is poor. International Journal of Gynecological Cancer, the official journal of ESGO, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. These genes also increase the risk of breast cancer. Mouse models of ovarian carcinoma have been developed that recapitulate many of the morphological features, biological behavior, and gene-expression patterns of selected subtypes of ovarian cancer. Ovarian cancer causes more deaths each year than any other gynecologic cancer in the U. The age of malignant ovarian cancer group was from 11 to 74, with an average age of 49. Specific areas of interest include clinical research and mechanistic approaches, drug sensitivity and resistance, gene and antisense therapy, pathology, markers, and prognostic indicators,. The Journal acts as a focus for publication of major clinical and laboratory research, as well as publishing solicited manuscripts on specific subjects from experts, case reports and other information of interest to clinicians working in the clinical neurosciences. 12–14 Consistent with this observation are estimates that at least 5% to 10% of all epithelial ovarian carcinoma cases result from hereditary predisposition, 15–18 with the germline inheritance of a mutant gene. Ovarian cancer affects women of all ages but is most commonly. ROMA scores alone are not sufficient for triaging patients; other clinical information should also be incorporated into the assessment. 5 deaths per 100,000 women in 2010. Jscholar is an open access publisher of peer reviewed journals and research articles, which are free to access, share and distribute for the advancement of scholarly communication. This article is intended to provide family physicians and other interested colleagues with data that are relevant to everyday practice. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. Clinical Ovarian and other Gynecologic Cancer is a peer-reviewed, semi-annual journal that publishes original articles describing various aspects of clinical and translational research in ovarian cancer. Clinical Oncology and Cancer Research English ISSN: 1674-5361 FREE 2009 - 2011 Title was 'Chinese Journal of Clinical Oncology' until 2008. International Journal of Immunotherapy and Cancer Research is an international journal in all areas of immunotherapy, including cellular immunology, non cellular immunotherapy (monoclonal antibodies), gene therapy, clinical immunology, hematology, oncology, allergology, rheumatology, and molecular biology, carcinogenesis, cancer cell biology, cancer genetics, infectious causes of cancer, tumor immunology, early detection and diagnosis, epidemiology, and cancer therapy with special interest. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments. and 14,180 deaths would result. The Hormone Imbalance and Cancer Risk Factor Connection. 929, ranking it in the top 10% of journals in the Obstetrics and Gynecologic category of the Journal Citation Reports and in the top 30% in the. Aim: The aim of this study was to evaluate the efficacy and safety of cell-free concentrated ascites reinfusion therapy (CART) on a large amount of ascites. Gynecologic Oncology Research and Practice will be closing on 17th June 2019 and is no longer accepting submissions. Our gynecologic experts are highly skilled at treating routine and advanced cases of ovarian cancer - and are among the most experienced in the United States. Publications. Opportunistic salpingectomy at benign gynecological surgery for reducing ovarian cancer risk: a 10-year single centre experience from China and a literature review. The journal publishes original research, reviews, previews, editorial comments and correspondence. OBJECTIVE: To explore the relationship between intrauterine device (IUD) use and risk of ovarian cancer through systematic review of the literature and meta-analysis. This study describes the unique cancer characteristics of male BRCA1/2 mutation carriers at our. It forms on the surface of the ovary in the epithelial cells or from the fallopian tube. are diagnosed with ovarian cancer and an estimated 14,000 women die from the disease. In addition to JAVELIN Ovarian 200, the avelumab ovarian cancer clinical development program includes several ongoing clinical trials investigating avelumab in combination with other therapies. In addition, the presence of CENPK significantly improved the sensitivity of CA125 or HE4 for predicting clinical outcomes of ovarian cancer patients. 198, ranking the journal within the top quartile of all obstetrics and gynecology journals and within the top third of all oncology journals. While obesity is already a known risk factor for this particularly deadly type of cancer, researchers at Ohio State are working to gain a better understanding of the link in order to determine if patients who develop pancreatic cancer because they are obese could respond better to certain therapies. Clinical Ovarian Cancer. Ultrasound has been utilized in several ovarian cancer screening trials in asymptomatic women in order to detect ovarian cancer at early stages where survival rates are high. “The identification of the fallopian tube as the origin of high-grade pelvic serous carcinomas has the potential to have significant clinical impact on the reduction of mortality associated with ovarian cancer. Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Home > Research and Education > Find a Scientific Publication > Myeloid Growth Factors Version 22017 Nccn Clinical Practice Guidelines In Oncology Myeloid Growth Factors, Version 2. Follow-up for ovarian cancer usually includes blood tests for tumor markers or hormones that help recognize recurrence. The journal focuses on research that provides new insights into ovarian functions as well as prevention and treatment of diseases afflicting the organ. In contrast to other malignancies such as melanoma or renal cell cancer, immunotherapy has not been approved for the treatment of ovarian cancer; however, several thousand patients will be included in front-line trials coming up in the next year to elucidate the role of immunotherapy in ovarian cancer. Learn more about how to assess your risk, and see Memorial Sloan Kettering's screening recommendations. If verified in an ongoing clinical trial, it. Author Wim Ceelen (UGent) and Michael F Flessner Organization. A number of authors have evaluated traditional clinical parameters such as histology, grade, stage, and ascites as predictors for poor outcome in patients with ovarian cancer (3, 30, 31). Some of the Gynecologic cancers are ovarian cancer, cervical cancer, uterine cancer, vulvar cancer and vaginal cancer. Alvarez has served on study sections for the NCI Clinical Oncology Section and the Department of Defense’s Ovarian Cancer Research Program. Pages in category "Oncology journals" The following 117 pages are in this category, out of 117 total. In fact, eighty percent of preadolescent malignant ovarian tumors are GCTs. Stage IIIC Ovarian Cancer Prognosis. OBJECTIVE: To explore the relationship between intrauterine device (IUD) use and risk of ovarian cancer through systematic review of the literature and meta-analysis. However, these tumours are rare, occurring annually in approximately 3. Purpose: This study aimed to investigate the potential prognostic impact of nuclear factor erythroid 2-related factor 2 (NRF2) and progesterone receptor A (PRA)/progesterone receptor B (PRB) in ovarian cancer patients which might be the rationale for putative new treatment strategies. In 2015, the American Cancer Society estimated that 21,290 new cases of ovarian cancer would be diagnosed in the U. Clinical Ovarian Cancer & Other Gynecologic Malignancies;. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches. Proteomics and Biomarkers for Ovarian Cancer Diagnosis Annals of Clinical & Laboratory Science. The journal is most prominent among the top oncology journals. Related Journals of Ovarian cancer. Nutrition And Ovarian Cancer: 5 Factors In Prevention And Management Share Tweet Google+ Pinterest LinkedIn Tumblr Email + Ovarian cancer is one of the harder forms of cancer to diagnose, which means that many women have more advanced disease by the time it's detected than they might with other types of cancer - and that means more. A number of factors influence the success of treatment for ovarian cancer. by Bethany R. DATA SOURCES: We searched MEDLINE, EMBASE, Cochrane Library, Web of Science Core Collection from inception to June 2018. The journal focuses on research that provides new insights into ovarian functions as well as prevention and treatment of diseases afflicting the organ. The International Journal of Gynecology & Obstetrics publishes articles on all aspects of basic and clinical research in the fields of obstetrics and gynecology and related subjects, with emphasis on matters of worldwide interest. Learn more about how to assess your risk, and see Memorial Sloan Kettering's screening recommendations. Ovarian cancer (OC) is the fifth most common cause of cancer death in women. It covers research on the detection, diagnosis, prevention, and treatment of ovarian cancer. The journal publishes original research, reviews, previews, editorial comments and correspondence. Objective To assess the associations between chronic HBV infection and risk of all cancer types. At the Oncology Clinical Pathways Congress, Chadi sat down with a host of experts to discuss pathway integration in value-based care models, OCM and other APMs, and the increasing role of employers in value-based care and payment. Ovarian cancer, commonly diagnosed among women between 55 and 64 years of age, causes more deaths in women than any other type of gynecologic cancer. Ovarian germ cell tumours (GCTs) account for approximately five percent of all ovarian cancers and are most commonly diagnosed in young women. In many families, the genetic changes associated with hereditary ovarian cancer are unknown. This includes: clinical radiotherapy, combined modality treatment, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects relevant to oncology, particularly in the field of imaging, dosimetry and radiation therapy planning. Regulation of immune infiltration in breast and ovarian cancer. Impact Factor List 2015 American Journal of Alzheimers Disease and Other Dementias: 1533-3175 American Journal Of Clinical Oncology-Cancer Clinical Trials. View More ». Despite recent promising advances in cancer research, there are still surprising gaps in the fundamental knowledge about ovarian cancer. As shown in Table III, the positive expression rates of HPSE at both the mRNA and protein levels in malignant ovarian tumors were significantly higher than the rates in benign tumors and controls (p=0. Our multidisciplinary care teams also include pathologists, pharmacists and advanced practice nurses with expertise in ovarian cancer and other gynecologic cancers. Young women with cancer or other serious illnesses that require chemotherapy or pelvic radiation are at risk of primary ovarian insufficiency because these agents may cause profound and rapid follicular atresia. Contemporary Clinical Trials is the new title for the previously published journal, Controlled Clinical Trials. True or False. Materials and Methods Expression levels of the different splicing factors were analyzed in physiological epithelial ovarian tissue samples, primary tumors, and metastatic samples of patients with a diagnosis of epithelial ovarian cancer using quantified reverse transcription polymerase chain reaction analysis. 86* Index Copernicus value: 85. Mercy Medical Center is a Baltimore, MD hospital sponsored by the Sisters of Mercy. Infórmese sobre el cáncer ginecológico (español / Spanish) "Striving for a Healthier Tomorrow, Today" NJ statewide symposium on gynecologic cancer held on November 19, 2015. Key to this is the capacity of tumor cells to escape suspension-induced apoptosis (anoikis), which also underlies their resistance to chemotherapy. Clinical Ovarian Cancer is the world's premier peer-reviewed, tumor-specific, clinical oncology journal devoted to publishing clinically relevant articles on detection, diagnosis, prevention, and. Clinical Ovarian and other Gynecologic Cancer is devoted to articles on detection, diagnosis, prevention Clinical Ovarian and other Gynecologic Cancer is a peer-reviewed, semi-annual journal that publishes original articles describing various aspects of clinical and translational research in ovarian cancer. Kenneth Lin. The Cancer Genome Atlas also showed that, in addition to the 30% of patients with high-grade serous ovarian cancer who lose BRCA due to germline or somatic mutations or hypermethylation, there is a further subset of around 20% who have rare alterations in various other members of the homologous recombination DNA repair pathway, such as EMSY. The purpose of this study was to explore quality of life (QoL) and the factors influencing QoL in gynecological cancer patients. Genetic epidemiology is the branch which deals with the role of genetic factors in determinant health and sickness in families and in populations, and therefore the interaction of such genetic factors with environmental factors. Journal of Clinical Oncology Journal of Oncology Practice Journal of Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology. In December 2011, two positive phase III trials1, 2 that assessed bevacizumab in patients with ovarian cancer were reported in the New England Journal of Medicine; these results led to the EMA approval of the drug as first-line treatment in combination with carboplatin and paclitaxel for this disease. Opportunistic salpingectomy at benign gynecological surgery for reducing ovarian cancer risk: a 10-year single centre experience from China and a literature review. Remedy Publications has launched this journal to make it an Open Platform for gynecologists and Obstetricians read, share, and publish most recent updates in this field of research. In 2015, the American Cancer Society estimated that 21,290 new cases of ovarian cancer would be diagnosed in the U. The clinical trials on this list are for ovarian cancer. Medicine Journal Impact Factor List provide the complete list of journals with last 10 years impact factor, hindex and sjr impact factor. Embryologist. en with gynecologic malignancies, only 0. RRBSO has an important impact on breast cancer risk in this population; the 50 % reduction in breast cancer incidence associated with premenopausal RRBSO in high-risk women would also need to be considered in these prospective studies before changing clinical practice for ovarian cancer prevention among BRCA1/2 mutation carriers. To assess late toxicity, quality of life and oncological outcome after consolidative whole abdominal radiotherapy (WART) following cytoreductive surgery and carboplati. In fact, eighty percent of preadolescent malignant ovarian tumors are GCTs. Clinical Sarcoma Research Alternative link English EISSN: 2045-3329 FREE 2011. The significance of this research is that it may help in our understanding of risk factors for progression of ovarian cancer. Some of the Gynecologic cancers are ovarian cancer, cervical cancer, uterine cancer, vulvar cancer and vaginal cancer. Journal of Ovarian Research, Clinical Ovarian and other Gynecologic Cancer, Journal of Uterus & Ovary, Polycystic ovary syndrome journals, Clinical Ovarian and other Gynecologic Cancer, Middle East Fertility Society Journal, Reproductive BioMedicine Online, Advances in Reproductive Sciences, Ovarian Cancer Journal, Human Reproduction Update. Forestry Commission Clinical Ovarian and other Gynecologic Cancer Kadmoniyot Gender and History International Journal of Tuberculosis and Lung Disease. UofL Brown Cancer Center is dedicated to the best diagnosis and treatment of ovarian cancer. Despite extensive efforts to improve the detection and treatment of ovarian cancer, the majority of affected women still succumb to the disease. Epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer collectively referred to as “ovarian cancer”, is a heterogeneous disease with unique molecular, pathologic and clinical features that afflicts approximately 22,400 women in the U. Articles investigating gynecologic cancer (endometrial, ovarian, and breast) incidence in diabetic patients were extracted. Complete Cancer Care — From Diagnosis to Survival Houston Methodist Gynecologic Oncology Associates in Sugar Land delivers high-quality, individualized and compassionate care for the treatment of uterine, ovarian, cervical and other female reproductive system cancers. By performing molecular analyses of 2,579 TCGA gynecological (OV, UCEC, CESC, and UCS) and breast tumors, Berger et al. However, concentrations of all three immunoglobulins in the endometriosis group did not differ from those in the other two groups (p>0. It is the world's leading nonprofit organization dedicated exclusively to saving more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. Most women with breast cancer don't have a family history of the disease. Although risk factors often influence the development of cancer, most do not directly cause cancer. com, Elsevier’s leading platform of peer-reviewed scholarly literature. 9]) ovarian cancer, occurring 5–10 years after the index surgery. Symptoms are rare and tumors are usually detected during a routine pelvic exam or Pap test. , mother, daughter, or sister) with the disease. Gynecology & Obstetrics is the medical and surgical specialty that focuses on the research prospectus of reproductive system in females that includes Archives of gynecology and obstetrics, HELLP Syndrome in Pregnancy, Gallbladder disorder in post and pre-pregnancy, Cosmetology in vagina, Vaginal Surgery, Drug Treatment in Gynecologic Oncology. It ranks fourth in cancer deaths among women and causes more deaths than any other cancer of the female reproductive system. Gynecologic oncology at Massey. Stage IIIC Ovarian Cancer Prognosis. Journal of Surgery & Clinical Practice (JSCP) is a medical journal that publishes articles based on global advancement of surgical research, education and clinical practice. Our Ovarian Cancer Clinical Trials MD Anderson leads the nation in innovative research into the causes, prevention, detection and treatment of ovarian cancer. Gynecologic Cancer Comprehensive Brochure : Detailed information about each type of gynecologic cancer, including signs, symptoms, risk factors, and prevention. 2010; 40(3): 218-225. and 225,000 women worldwide annually [1,2]. Current Trends in Gynecologic Oncology, Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Journal of Ovarian Research. The European Journal of Cancer (EJC) integrates preclinical, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric. Gynecologic Cancer Comprehensive Brochure : Detailed information about each type of gynecologic cancer, including signs, symptoms, risk factors, and prevention. Clinical Sarcoma Research Alternative link English EISSN: 2045-3329 FREE 2011. Thyroid cancer is the cause of less than 1% of all cancer deaths, making this a very low-risk disease when caught early. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. In conclusion, we identified that CENPK was specifically upregulated in ovarian cancer cells and can be used as a novel tumor marker of ovarian cancer. O'Malley D Azodi M Makkenchery A Tangir J McAlpine J Kelly M. Journal of Women's Health Care, Advances in Cancer Prevention, Archives in Cancer Research, Breast Cancer: Current Research, Cervical Cancer: Open Access, Cancer Medicine & Anti Cancer Drugs, Journal of Ovarian Research, Clinical Ovarian and Other Gynecologic Cancer, Clinical Ovarian Cancer, Ovarian Cancer Journal Articles, Clinical Ovarian. The authors present a well written review on the current status of p53 mutation/dysfunction in various gynecologic cancers such as endometrial, cervical, and ovarian cancer. Alvarez has served on study sections for the NCI Clinical Oncology Section and the Department of Defense’s Ovarian Cancer Research Program. by Bethany R. , mother, daughter, or sister) with the disease. Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. Clinical Pathology is medical area of expertise that is related to the diagnosis of disease based on the laboratory analysis of bodily fluids, such as blood, urine, and tissues using the tools of chemistry, microbiology, hematology and molecular pathology. Articles investigating gynecologic cancer (endometrial, ovarian, and breast) incidence in diabetic patients were extracted. Ovarian cysts, also known as ovarian masses or adnexal masses, are frequently found incidentally in asymptomatic women. Results The strong evidence for a positive association between diabetes mellitus and the risk for cancer indicates that energy intake in excess to energy expenditure, or the sequelae thereof, is involved in gynecological. 3 Bevacizumab is currently the most widely. Journal of Obstetrics and Gynecology is the best among the high Impact Factor Journals in Obstetrics and Gynecology. The Data Visualizations Tool provides detailed statistics. In many families, the genetic changes associated with hereditary ovarian cancer are unknown. The Cancer Genome Atlas also showed that, in addition to the 30% of patients with high-grade serous ovarian cancer who lose BRCA due to germline or somatic mutations or hypermethylation, there is a further subset of around 20% who have rare alterations in various other members of the homologous recombination DNA repair pathway, such as EMSY. Contributions include original clinical studies, review articles, and experimental investigations with clear clinical relevance. Journal of Ovarian Research is an open access, peer reviewed, online journal that aims to provide a forum for high-quality basic and clinical research on ovarian function, abnormalities, and cancer. A 2004 study by Navo et al. Arash Asher Honored by Hundreds of. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) Young et al. Medicine Journal Impact Factor List provide the complete list of journals with last 10 years impact factor, hindex and sjr impact factor. In December 2011, two positive phase III trials1, 2 that assessed bevacizumab in patients with ovarian cancer were reported in the New England Journal of Medicine; these results led to the EMA approval of the drug as first-line treatment in combination with carboplatin and paclitaxel for this disease. Most of the research on nutrition and cancer has been reductionist; that is, a particular food or a nutrient has been studied in relation to its impact on tumor formation/regression or some other end point of cancer at a particular site in the body. 2 > Ovarian cancer caused the most fatalities with 9. Listing a study does not mean it has been evaluated by the U. ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post JOP DAiS. Benign Ovarian Tumors Benign ovarian tumors at a glance. Clinical Ovarian Cancer. The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D Lee JY, Kim JW, Lim MC, Kim S, Kim HS, Choi CH, Yi JY, Park SY, Kim BG, on behalf of KGOG investigators. It is the leading cause of death amongst gynecologic cancers. While significant advances have been made in surgical and chemo-based treatments for ovarian cancer, the survival rates have only modestly improved. At UCLA, comprehensive care for breast cancer is provided through Division of Hematology/Oncology. Indian Journal of Cancer (ISSN 0019-509X), the show window of the progress of oncological sciences in India, was established in 1963. The incidence rate has remained relatively stable over the past 30 years with a 5-year relative survival of about 35%. testing in ovarian cancer clinical practice. Other ovarian cancer headlines of note over the last year: Trametinib Tx Shows Promise in Tough-to-Treat LGSOC No Overall Survival Benefit With Bevacizumab for Ovarian Cancer. Follow-up for ovarian cancer usually includes blood tests for tumor markers or hormones that help recognize recurrence. As shown in Table III, the positive expression rates of HPSE at both the mRNA and protein levels in malignant ovarian tumors were significantly higher than the rates in benign tumors and controls (p=0. Positive expression of HPSE in ovarian cancer and its relationship with clinicopathological factors. Purpose: This study aimed to investigate the potential prognostic impact of nuclear factor erythroid 2-related factor 2 (NRF2) and progesterone receptor A (PRA)/progesterone receptor B (PRB) in ovarian cancer patients which might be the rationale for putative new treatment strategies. The searchable list includes journal home pages, ISNN numbers, and links for browsing journal articles in PubMed. It publishes peer reviewed original research articles, as well as a wide range of news, book reviews, biographical, historical and educational articles and a lively correspondence section. In December 2011, two positive phase III trials1, 2 that assessed bevacizumab in patients with ovarian cancer were reported in the New England Journal of Medicine; these results led to the EMA approval of the drug as first-line treatment in combination with carboplatin and paclitaxel for this disease. So, this study was carried out to assess the knowledge and awareness of Jordanian women about ovarian cancer symptoms and risk factors. John is the principal investigator for Gynecologic Oncology Group clinical trials and multiple pharma studies. Introduction. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. Elena , Paige A. The purpose of this study was to explore quality of life (QoL) and the factors influencing QoL in gynecological cancer patients. Some things reduce a woman’s risk of developing ovarian cancer. Related Journals of Ovarian cancer. Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer. For epithelial ovarian cancer, CA-125 is the tumor marker used most often to check for recurrence. Follow-up for ovarian cancer usually includes blood tests for tumor markers or hormones that help recognize recurrence. It forms on the surface of the ovary in the epithelial cells or from the fallopian tube. The Journal, which presents research, clinical opinions and case reports from the brightest minds in gynecologic surgery. 9]) ovarian cancer, occurring 5–10 years after the index surgery. Germ cell ovarian cancer: Germ cell tumors account for about 5% of ovarian cancers. For a complete description of factors associated with an increased or decreased risk of ovarian cancer, refer to the Factors With Adequate Evidence of an Increased Risk of Ovarian, Fallopian Tube, and Primary Peritoneal Cancer section in the PDQ summary on Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Prevention for more information. Publications. com, Elsevier’s leading platform of peer-reviewed scholarly literature. They begin in the egg-producing cells. The Editors encourage submission of research and opinion papers on radiation oncology as it is practiced today-especially with focus on imaging, contouring, target delineation, simulation, treatment planning, immobilization, organ motion, patient safety, quality measurement, and other practical issues. However, there were about 12,800 new cases and 4,200 deaths related to cervical cancer in 1999. It is the leading cause of death amongst gynecologic cancers. 007, respectively), while no statistically significant difference was observed. Information about ovarian cancer symptoms and treatments. A nurse is speaking to a local women's group about the various types of cancer affecting the female reproductive tract. Clinical Ovarian Cancer & Other Gynecologic Malignancies;. | N Engl J Med 2018; 379:1955-1957 Cervical cancer is the fourth most frequently diagnosed cancer and the fourth leading cause of cancer-related death in women worldwide. The Foundation for Women's Cancer (FWC) steadily pursues its mission of supporting research, education and public awareness of gynecologic cancers. and 225,000 women worldwide annually [1,2]. Nutrition And Ovarian Cancer: 5 Factors In Prevention And Management Share Tweet Google+ Pinterest LinkedIn Tumblr Email + Ovarian cancer is one of the harder forms of cancer to diagnose, which means that many women have more advanced disease by the time it's detected than they might with other types of cancer - and that means more. The four subtypes of epithelial ovarian cancer are serous, mucinous, clear cell, and endometrioid, with serous being the most common variety. The fourth International Ovarian Cancer Consensus Meeting held in Vancouver in June 2010 on behalf of Gynecologic Cancer InterGroup (GCIG) established definition of PFI as the interval from the last date of platinum dose until progressive disease is documented. We sought to know the impact of EMT on clinical variables and on several subtyping schemes, including genomic aberration-based molecular subtyping. The Annals of Gynecologic cancer is aimed at publishing original research articles. Reports on clinical trials are encouraged. Listing a study does not mean it has been evaluated by the U. Publications. Collier (Editor) Ovarian cancer is the third most diagnosed gynecologic cancer and the first leading cause of death from all of gynecological malignancies. Gynecologic Oncology has an Impact Factor of 3. Read the latest articles of Clinical Ovarian and Other Gynecologic Cancer at ScienceDirect. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values. Our Ovarian Cancer Clinical Trials MD Anderson leads the nation in innovative research into the causes, prevention, detection and treatment of ovarian cancer. The journal is published nine times a year and offers great value to the medical field and to gynecologic. In conclusion, we identified that CENPK was specifically upregulated in ovarian cancer cells and can be used as a novel tumor marker of ovarian cancer. Gynecologic Oncology's Impact Factor increases to 4. Endometrial cancer cell line, AN3CA and ovarian cancer cell line, OVCAR-3 also have missense mutations, c. Clinical Ovarian and other Gynecologic Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of ovarian and other. Epithelial ovarian cancer is the most common and accounts for 85–89 percent of ovarian cancers. There are successful clinical trials on the use of novel targeted agents for the treatment or rare cancer syndromes, e. Ovarian cancer is the 5th leading cause of cancer deaths in women. Hormone Therapy in Primary Ovarian Insufficiency. Epithelial ovarian cancer is the deadliest gynecologic malignancy [1]. 26 Annually, more than 22,000 women in the U. A comprehensive listing of over 250 oncology and related journals. Indian Journal of Cancer (ISSN 0019-509X), the show window of the progress of oncological sciences in India, was established in 1963. The clinical trials on this list are for ovarian cancer. Skin metastases manifest in fewer than 0. "Fortunately these types of cysts are not typically related to infertility or cancer and most women can complete a healthy pregnancy to term if she has an ovarian cyst," says Dr. Gynecologic Cancer Comprehensive Brochure : Detailed information about each type of gynecologic cancer, including signs, symptoms, risk factors, and prevention. Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) Young et al. Learn more about participating in a clinical trial at Norton Healthcare. Proteomics and Biomarkers for Ovarian Cancer Diagnosis Annals of Clinical & Laboratory Science. Use of talcum powder. 9]) ovarian cancer, occurring 5-10 years after the index surgery. Cancer, 2009. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric. We sought to know the impact of EMT on clinical variables and on several subtyping schemes, including genomic aberration-based molecular subtyping. Jscholar is an open access publisher of peer reviewed journals and research articles, which are free to access, share and distribute for the advancement of scholarly communication. This type of ovarian cancer is divided into serous, mucinous, endometrioid, clear cell, transitional and undifferentiated types. The European Journal of Cancer (EJC) integrates preclinical, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. It is believed that the majority of HGSC originate in the distal fallopian tube epithelium and that this histotype is most closely associated with hereditary breast and ovarian cancer syndrome (e. However, concentrations of all three immunoglobulins in the endometriosis group did not differ from those in the other two groups (p>0. Clinical Ovarian Cancer & Other Gynecologic Malignancies. Approximately 5% to 10% of ovarian cancers are familial and 3 distinct hereditary patterns have been identified: ovarian cancer alone, ovarian and breast cancers, or ovarian and colon cancers. METHODS:Demographic and clinicopathologic information were obtained from the Surveillance, Epidemiology and End Results Program between 1988 and 2001. The significance of this research is that it may help in our understanding of risk factors for progression of ovarian cancer. International Journal of Immunotherapy and Cancer Research is an international journal in all areas of immunotherapy, including cellular immunology, non cellular immunotherapy (monoclonal antibodies), gene therapy, clinical immunology, hematology, oncology, allergology, rheumatology, and molecular biology, carcinogenesis, cancer cell biology, cancer genetics, infectious causes of cancer, tumor immunology, early detection and diagnosis, epidemiology, and cancer therapy with special interest. Ovarian cancer is believed to occur due to changes in cell DNA. Journal of Clinical Oncology Journal of Oncology Practice Journal of Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology. While other histologies show microarray gene expression patterns that are unique to their organ of origin, CCC shows a remarkably similar gene expression pattern in the endometrium, kidney, and ovary [1]. OBJECTIVE: To explore the relationship between intrauterine device (IUD) use and risk of ovarian cancer through systematic review of the literature and meta-analysis. She cochairs the Gynecologic Cancer Center of Excellence and she is the chair for gynecologic disease team. However, these tumours are rare, occurring annually in approximately 3. Investigations relating. Norton Cancer Institute is at the forefront of cancer treatment research. Again, although the trial was not specific to ovarian with uroepithelial cancer of the bladder who ingested her cancer, it was the only other clinical trial reporting adverse first dose of (3 g) of amygdalin and also ingested a daily events related to CAM use that was identified as a result of dose of 4800 mg vitamin C. They begin in the egg-producing cells.